Does garlic affect vascepa's cholesterol lowering ability?

What's the impact of garlic on Vascepa's effectiveness?

Vascepa, or icosapent ethyl, is a prescription medication used to treat high levels of triglycerides and reduce the risk of cardiovascular events [1]. One of the most commonly asked questions about Vascepa is whether it can be taken with other natural remedies, such as garlic, and how these interactions might affect its cholesterol-lowering ability.

How does Vascepa work?

Vascepa works by preventing the buildup of triglycerides in the blood and reducing inflammation in the body. The active ingredient, icosapent ethyl, is a concentrated form of an omega-3 fatty acid, also found in fish oil.

Does garlic interact with Vascepa?

While there isn't much research on the direct interaction between garlic and Vascepa, we can look at the individual effects of garlic on cholesterol and triglyceride levels. Garlic has been shown to have a mild effect on reducing total and LDL ("bad") cholesterol levels, but its impact on triglycerides is less clear [2]. In one small-scale study, participants who consumed garlic supplements experienced a slight decrease in triglyceride levels, but the effect was not statistically significant.

What about potential synergies?

Some researchers suggest that the omega-3 fatty acids in Vascepa might enhance the cholesterol-lowering effects of garlic. Omega-3s have anti-inflammatory properties and may help to reduce the production of cholesterol in the liver [3]. However, more research is needed to understand the specific interactions between garlic and Vascepa.

Patent expiration and competition

The Vascepa patent is set to expire in 2027 [4]. As more generic versions of the medication become available, there may be a rise in studies examining its interactions with common natural remedies like garlic. This could eventually lead to a better understanding of how these interactions affect its effectiveness.

Sources

[1] https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/205554s003lbl.pdf
[2] Singh et al. (2014). Garlic and cardiovascular diseases: A review. Journal of Food Science and Technology, 51(5), 1323–1331.
[3] Harris et al. (2017). Omega-3 fatty acids and cardiovascular disease: an evidence-based update. Mayo Clinic Proceedings, 92(12), 1834–1841.
[4] https://www.drugpatentwatch.com/patent/205554